Albanese comes to DUHS from NewYork-Presbyterian Hospital, where he’s currently group senior vice president and chief medical officer of the $9.2 billion, 10-hospital academic health system. He will start his new role at Duke on Jan. 17, 2022.
“Dr. Albanese is a passionate and collaborative executive with deep experience in leading cutting-edge academic health systems such as ours in becoming the best place to work, delivering highest-quality patient care, and helping to advance our other missions, including research, education and community health,” said A. Eugene Washington, M.D., chancellor for health affairs and DUHS president and CEO.
“Given his impressive achievements and commitment to our values, I am confident that Duke University Health System will begin a new era of excellence and impact under his leadership,” Washington said.
As executive vice president, Albanese will serve as the senior leader overseeing the timely execution of DUHS goals and strategic priorities. He will work with other clinical enterprise leaders to deliver outstanding outcomes and care across Duke’s network, from the hospital to ambulatory clinics to care in homes and the community. He will also bring new insights to manage the organization’s COVID pandemic response, to support the health system’s faculty and staff and to further advance the clinical enterprise strategic plan.
“I am honored to accept this position and to join the Duke family,” Albanese said. “I look forward to growing Duke’s footprint in the community and building upon the existing quality improvement work that contributes to Duke’s reputation as a world-class health system.”
Albanese succeeds William Fulkerson, M.D., who held the executive vice president position since 2010 and announced he would step down at the end of the year.
In his current role at NYP, Albanese is responsible for the chief medical officers and all eight service lines, including oversight for enterprise clinical standardization, network integration and medical affairs. He also oversees quality, safety, and infection prevention and control for the enterprise.
His more than 25 years of health care management experience includes overseeing the redesign of service line strategy at NYP to drive integration and single standards of care across 10 hospitals and two medical schools, Columbia Vagelos College of Physicians and Surgeons and the Weill Cornell Medical College.
He also served as the COO of NewYork-Presbyterian’s Morgan Stanley Children’s Hospital and the Sloane Hospital for Women, which is located within the Children’s Hospital.
Prior to NYP, Albanese held senior leadership roles at Stanford University and Stanford Health Care. A respected surgeon-scientist and clinical investigator, he co-directed the team that pioneered in-utero fetal surgery.
Albanese received his medical degree from SUNY Health Science Center in Brooklyn and was a resident and chief resident in general surgery at Mount Sinai Medical Center. He completed pediatric general surgery and critical care research fellowships at Children’s Hospital of Pittsburgh. Albanese also holds a Master’s in Business Administration from the Leavey School of Business at Santa Clara University.
“Dr. Albanese is a seasoned health care leader who possesses a collaborative management style and is committed to the same core ideals we value here at Duke,” said Duke University President Vincent E. Price.
###